---
first_name: David
last_name: Hulcoop
role: Executive Director
picture: David-Hulcoop-Jun23.png
organisation: EMBL-EBI
organisation_logo: embl-ebi.png
orcid: 0000-0003-1323-1759
order: 1
---

David has a PhD from the University of Cambridge in Organic Chemistry and conducted postdoctoral research at the University of Toronto in Canada. 

He joined GSK in 2007 initially in the Process Chemistry group to develop manufacturing processes for small molecule therapies.  Through his time at GSK he has held project leadership and line management roles in R&D and led research and technology transfer programmes between R&D and Global Manufacturing. Before joining Open Targets David was engaged in developing and implementing strategic projects for GSK through a secondment to the office of the CEO and CFO as part of the CEO's Future Strategy Group. 

David joined Open Targets in 2017 as Strategy and Operations Director, and oversaw the management of a number of informatics and experimental target validation projects as well as ensuring the strategic deployment and operational translation of Open Targets. In 2023, he was appointed Executive Director of Open Targets.
